Literature DB >> 27168343

Best Use of the Tyrosine Kinase Inhibitors in Progressive Differentiated Thyroid Cancer: Discussion.

R M Tuttle1, Marcia S Brose2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27168343

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN: 1543-0790


× No keyword cloud information.
  2 in total

Review 1.  Can We Predict Differentiated Thyroid Cancer Behavior? Role of Genetic and Molecular Markers.

Authors:  Rita Niciporuka; Jurijs Nazarovs; Arturs Ozolins; Zenons Narbuts; Edvins Miklasevics; Janis Gardovskis
Journal:  Medicina (Kaunas)       Date:  2021-10-19       Impact factor: 2.948

2.  Teriparatide Replacement Therapy for Hypoparathyroidism During Treatment With Lenvatinib for Advanced Thyroid Cancer: A Case Report.

Authors:  Tommaso Porcelli; Francesca Sessa; Angela Caputo; Christian Catalini; Domenico Salvatore
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-17       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.